News Mylan and Biocon file Herceptin biosimilar in Europe First Herceptin biosimilar filed in EU, companies say.
Views & Analysis What doctors say about changes to the Cancer Drugs Fund Assessing HCPs’ social media comments about the new approach to cancer drug funding.
News NHS to fund Pfizer's Bosulif and Lilly's Alimta NICE is reviewing drugs from old Cancer Drugs Fund.
News UK grants patients early access to AbbVie/Roche leukaemia dr... Venetoclax still under review in Europe.
Views & Analysis Digital health round-up: Google Genomics, cancer bots & more A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
